Paushak Ltd has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026, with BSE Limited and the National Stock Exchange of India Ltd. The filing, submitted by Company Secretary Sagar Gandhi, details the company's environmental, social, and governance performance, including a workforce of 683 employees and workers and an export contribution of 17.54% to total turnover.

The company reported zero reportable accidents and nil fatalities for both employees and workers during FY26. Paushak Ltd, which manufactures specialty chemicals and intermediates, achieved a 27.10% reuse of treated effluent and maintained a Responsible Care certification valid until November 2026. The report confirms compliance with applicable environmental laws and regulations, including the Water and Air Acts.

Financial and Operational Metrics

The company’s paid-up capital stood at ₹ 1,232.85 Lacs. Operations are primarily concentrated in one national plant and two offices, serving 14 states domestically and 11 countries internationally. The table below summarizes key financial and operational disclosures from the report.

Environmental Performance

Paushak Ltd reported total energy consumption of 1,92,316.49 GJ for FY26, with Scope 1 emissions at 11,166.55 metric tonnes of CO2 equivalent and Scope 2 emissions at 10,963.06 metric tonnes. The company generated 18,635.23 metric tonnes of total waste, of which 18,154.86 metric tonnes were recovered through recycling or other recovery operations. Water withdrawal totaled 1,18,445 kiloliters, with a water intensity of 0.00005418 per rupee of turnover.

Governance and Stakeholder Engagement

The Board of Directors reviewed the company's performance against the National Guidelines on Responsible Business Conduct (NGRBC) principles annually. Mr. Jain Parkash, Whole-time Director, is responsible for the implementation and oversight of business responsibility policies. The company received 10 shareholder complaints and 10 customer complaints during the year, all of which were resolved with none pending at the close of the year.

Paushak Limited announced its audited financial results for the quarter and financial year ended 31st March, 2026, following a Board of Directors meeting held on 5th May, 2026. The statutory auditors, M/s. CNK & Associates LLP, Chartered Accountants, issued an unmodified audit opinion on the financial results, in compliance with Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company operates solely in the Speciality Chemicals segment, which constitutes the only reportable business segment. Subsequently, on 6th May, 2026, Paushak filed an intimation under Regulation 30 and Regulation 47 of the SEBI Listing Regulations, enclosing copies of newspaper advertisements related to the audited financial results published in The Indian Express (English) and Financial Express (Gujarati). The advertisements provided a QR Code and weblink to access the complete financial results on the company's website.

Financial Performance Overview

For the full financial year ended 31st March, 2026, Paushak reported revenue from operations of Rs. 21,860 lacs, compared to Rs. 21,095 lacs in the previous year. Total income for FY26 stood at Rs. 23,071 lacs versus Rs. 22,519 lacs in FY25. Profit after tax for the year came in at Rs. 3,933 lacs, declining from Rs. 4,938 lacs in FY25. Total comprehensive income for FY26 was Rs. 3,180 lacs, compared to Rs. 6,768 lacs in the prior year. Basic and diluted earnings per share for FY26 stood at Rs. 15.95, against Rs. 20.03 in FY25, with prior period figures restated to reflect the sub-division of shares and allotment of bonus shares in line with Ind AS 33. On a quarterly basis, Q4 net profit rose to Rs. 1,251 lacs from Rs. 960 lacs in Q4 FY25, while Q4 revenue from operations grew to Rs. 5,514 lacs from Rs. 5,236 lacs in the same period last year.

The following table summarises the key financial metrics for the year and the most recent quarter:

EBITDA Performance

On an operational efficiency basis, Paushak's Q4 EBITDA improved on a year-on-year basis. The following table presents the key EBITDA metrics for Q4:

Dividend Recommendation

The Board of Directors recommended a dividend of Rs. 2.50 per equity share (50%) on shares with a face value of Rs. 5 each for the financial year ended 31st March, 2026, subject to approval by shareholders at the ensuing Annual General Meeting. This compares to a dividend of Rs. 20 per share (200%) declared for the previous year. Paid-up equity share capital as at 31st March, 2026 stood at Rs. 1,233 lacs, with other equity excluding revaluation reserves at Rs. 38,363 lacs.